Chronic pain diseases and medical cannabis
Janosch Kratz discusses the importance of medical cannabis for chronic pain diseases.
EUMCA: Limit of 0.2% THC in CBD products should not change
Chair of the European Medicinal Cannabis Association (EUMCA) issues warning that raising limit for THC in CBD to 0.3% will risk patient safety.
How are different types of medical cannabis working for different diseases?
Dr David Moorhouse, General Neurologist, discusses the way that different diseases respond to different types of medical cannabis.
How cannabinoids can be used as pain medicine
Dr Daniela Tonucci, a consultant for over 10 years, talks us through the use of cannabinoids as pain medicine.
The EUMCA: Pioneering access to medicinal cannabis
Professor Trevor Jones, Chair at the European Medicinal Cannabis Association, speaks to Nishat about their plans for EU patient access to medicinal cannabis.
Expanding the portfolio of rigorous cannabinoid research with new funding opportunities
David Shurtleff, PhD, Deputy Director at the National Center for Complementary and Integrative Health, National Institutes of Health, discusses new funding opportunities for cannabinoid research.
Greenheart CBD: A green crop from seed to shelf
Here, we learn how about a different kind of green crop that grows in Ireland and the journey of that from seed to shelf as part of the Greenheart CBD story.
Attracting major investors: GreenLight on the international stage
In the last six months GreenLight Medicines has successfully out-licenced leads from its research, branching out internationally and attracting major investors.
The medical cannabis space: A successful targeted investment strategy
In this interview, David Engel from Full Moon Investments in the U.S., charts the firm’s successful targeted investment strategy – informed by industry-leading experience and expertise – including comments on the CBD hemp and medical cannabis space.
Elixinol launches new UK range of blended, full-spectrum CBD capsules
Elixinol has launched a new UK range of blended, full-spectrum CBD capsules using six original combinations developed to support good health and wellbeing.
Essential oils as a potential modulator of the endocannabinoid system
Dr Christian Löfke, responsible for research and product development at BioBloom, walks us through the rudiments of essential oils as a potential modulator of the endocannabinoid system.
The export of medicinal cannabis from Israel
Kathleen Denoodt shares with us what we need to know about the export of medicinal cannabis from Israel.
Cannabinoids in medicine part 5: Treating COVID-19
In this final article of a series of five, Oxford Cannabinoid Technologies will discuss their expertise on the use of cannabinoids in medicine when it comes to treating COVID-19.
Ilesol Pharmaceuticals: First European cannabinoid à la carte company
Here, Ilesol Pharmaceuticals discuss how they became the first European cannabinoid company to unlock this sector of the market.
CBDepot: The company with a “Valid” Novel Food Application
Here, CBDepot discuss how they worked with the European Commission to achieve a “valid” Novel Food Application.
EU and UK compliance with the novel food application for CBD isolate
Christian Hendriksen, VP of International Expansion at Mile High Labs, illustrates how they are continuing compliance with the novel food application to ensure safe and effective cannabinoids can be available to all.
COVID-19: A moment for legalising medical cannabis?
Here, Josh Smith talks us through the current pandemic and the recent history underlying the fight for legalising medical cannabis.
Can cannabidiol (CBD) treat epilepsy?
Here, OilsBySimpson Founder Kevin William Simpson, explains what current research shows about CBD’s effect on epilepsy and its applications as a treatment.
Stop drug testing and start impairment testing
A new public health app by DRUID® measures factors to give an overall score of impairment, evolving the classic idea of drug testing.
12 ways you can take cannabidiol (CBD)
Canna CBD Limited shares with us 12 ways you can take cannabidiol (CBD), including oils, tinctures, pills, edibles, as well as products for localised relief like bath salts, lotions, roll-ons and creams.
